SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-Apr-21 5:23 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Apr-21 | Option Exercise | 5,312 | $1.80 | $9,577.69 | 100% 0 to 5.31K | |
09-Apr-21 5:23 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Apr-21 | Market Option Sale (Planned) | 5,312 | $11.09 | $58,910.10 | (100%) 5.31K to 0 | 28% |
12-Mar-21 4:40 PM View: | Trillium Therapeutics Inc. (TRIL) | 10-Mar-21 | Option Exercise | 5,312 | $1.80 | $9,545.30 | 100% 0 to 5.31K | |
12-Mar-21 4:40 PM View: | Trillium Therapeutics Inc. (TRIL) | 10-Mar-21 | Market Option Sale (Planned) | 5,312 | $11.08 | $58,857.00 | (100%) 5.31K to 0 | 28% |
10-Feb-21 7:18 PM View: | Trillium Therapeutics Inc. (TRIL) | 09-Feb-21 | Option Exercise | 508 | $9.62 | $4,887.62 | 100% 0 to 0.51K | |
10-Feb-21 7:18 PM View: | Trillium Therapeutics Inc. (TRIL) | 09-Feb-21 | Market Option Sale (Planned) | 508 | $14.17 | $7,200.39 | (100%) 0.51K to 0 | 43% |
10-Feb-21 7:18 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Feb-21 | Option Exercise | 5,312 | $1.78 | $9,435.05 | 100% 0 to 5.31K | |
10-Feb-21 7:18 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Feb-21 | Market Option Sale (Planned) | 5,312 | $12.65 | $67,196.80 | (100%) 5.31K to 0 | 37% |
13-Jan-21 4:11 PM View: | Trillium Therapeutics Inc. (TRIL) | 11-Jan-21 | Option Exercise | 508 | $9.57 | $4,860.09 | 100% 0 to 0.51K | |
13-Jan-21 4:11 PM View: | Trillium Therapeutics Inc. (TRIL) | 11-Jan-21 | Market Option Sale (Planned) | 508 | $15.21 | $7,725.31 | (100%) 0.51K to 0 | 47% |
12-Jan-21 4:10 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Jan-21 | Option Exercise | 2,604 | $3.33 | $8,673.92 | 100% 0 to 2.6K | |
12-Jan-21 4:10 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Jan-21 | Market Option Sale (Planned) | 2,604 | $15.50 | $40,364.60 | (100%) 2.6K to 0 | 48% |
11-Jan-21 4:19 PM View: | Trillium Therapeutics Inc. (TRIL) | 07-Jan-21 | Option Exercise | 2,708 | $0.30 | $808.88 | 100% 0 to 2.71K | |
11-Jan-21 4:19 PM View: | Trillium Therapeutics Inc. (TRIL) | 07-Jan-21 | Market Option Sale (Planned) | 2,708 | $14.71 | $39,842.80 | (100%) 2.71K to 0 | 45% |